Headline News about Karuna Therapeutics Inc
![](https://investorplace.com/wp-content/uploads/2023/03/ubs-stock-bank-sign-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/20/aapharma_3.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/09/pills-1.jpg)
![](https://www.investors.com/wp-content/uploads/2022/05/Stock-drugsdish-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_5981.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Karuna Therapeutics
March 02, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Looking Into Karuna Therapeutics's Return On Capital Employed
February 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Karuna Therapeutics's Future
January 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/06/image-apple-logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/02/image-target2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/03/krtx_logo_light__5ab4f4e09bf3f82a517f93702cc13b5a.png?width=1200&height=800&fit=crop)
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
February 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
Via Benzinga
5 Analysts Have This to Say About Karuna Therapeutics
December 09, 2022
Via Benzinga
What 5 Analyst Ratings Have To Say About Karuna Therapeutics
December 09, 2022
Via Benzinga
Where Karuna Therapeutics Stands With Analysts
December 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30579.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Karuna Therapeutics
December 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/06/vaccine-4892048.jpg?width=1200&height=800&fit=crop)
Looking Into Karuna Therapeutics's Return On Capital Employed
November 23, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/710145/cost-vs-value.jpg)
My 3 Top Biotech Stock Picks for 2023
November 22, 2022
Via The Motley Fool
![](https://www.investors.com/wp-content/uploads/2022/11/Stock-neurologybrain-02-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_2116.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28963.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28955.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6692.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/706506/a-scientist-uses-a-pipette-to-work-with-medical-samples-1.jpg)
![](https://cdn.pixabay.com/photo/2020/06/11/19/51/mockup-5288033_960_720.jpg)
Opportunities In Large Cap Growth And Small Cap
October 20, 2022
Via Talk Markets
![](https://prudentbiotech.com/wp-content/uploads/2022/10/Yield-and-XBI.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4594.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.